ADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2022 Earnings Call Transcript

So that’s the best answer I can give you, and I hope that that’s okay. And I just think, look, there’s more data coming out. There’s more data that’s published all the time. And I think as we continue to make progress with the product utilization and penetration, I’m excited for what lies ahead for the future, for the PI population and for our company.

Kristen Kluska: Great. Looking forward to seeing what you have in store for us this year.

Adam Grossman: Stay tuned, Kristen. We will hopefully not disappoint.

Operator: Ladies and gentlemen, this concludes our question-and-answer portion of the call. I’d like to turn it back over to Adam for additional closing remarks.

Adam Grossman: Thank you, everybody. I just want to thank you all for your interest in ADMA Biologics. We appreciate your continued support. Donate plasma, you’ve got plasma centers near you. And we hope to continue to keep the shareholders happy, keep the patients happy. And again, thank you to my staff, the whole team, we can’t do it without you. So all of our advisers and everybody, keep fighting the good fight and rock on. Take care, everybody.

Operator: Thank you. Ladies and gentlemen, this concludes the conference call for today. We appreciate your participation, and you may now disconnect.